UB Paderborn / Katalog / Suche / in CDI

1 – 21 von 21

Sortiert nach

Sustained 52‐week efficacy and safety of triple therapy with dapagliflozin plus saxagliptin versus dual therapy with sitagliptin added to metformin in patients with uncontrolled type 2 diabetes

Diabetes, obesity & metabolism, 2019-04, Vol.21 (4), p.883-892

2019

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and tolerability of saxagliptin compared with glimepiride in elderly patients with type 2 diabetes: a randomized, controlled study (GENERATION)

Diabetes, obesity & metabolism, 2015-07, Vol.17 (7), p.630-638

2015

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of saxagliptin compared with acarbose in Chinese patients with type 2 diabetes mellitus uncontrolled on metformin monotherapy: Results of a Phase IV open‐label randomized controlled study (the SMART study)

Diabetes, obesity & metabolism, 2017-11, Vol.19 (11), p.1513-1520

2017

Link zum Volltext

Verfügbarkeit prüfen

Initial combination therapy with saxagliptin and metformin provides sustained glycaemic control and is well tolerated for up to 76 weeks

Diabetes, obesity & metabolism, 2011-06, Vol.13 (6), p.567-576

2011

Link zum Volltext

Verfügbarkeit prüfen

Saxagliptin and sitagliptin in adult patients with type 2 diabetes: a systematic review and meta-analysis

Diabetes, obesity & metabolism, 2012-06, Vol.14 (6), p.481-492

2012

Link zum Volltext

Verfügbarkeit prüfen

Saxagliptin: A New Dipeptidyl Peptidase-4 Inhibitor for Type 2 Diabetes

Cardiology in review, 2010-07, Vol.18 (4), p.213-217

2010

Link zum Volltext

Verfügbarkeit prüfen

Combination of antioxidants and a hepatoprotector in the treatment of patients with diabetic distal symmetric polyneuropathy

Likars'ka sprava, 2010-04 (3-4), p.68

Hryb, V A

2010

Link zum Volltext

Verfügbarkeit prüfen

Effect of a complex treatment, including glutargin and erbisol on the blood plasma content of protein P53, apoptotic markers of type II, activity of caspases and the level of sCD 117 in patients with autonomic-vascular dystonia

Likars'ka sprava, 2008-04 (3-4), p.49

Krychun, I I

2008

Link zum Volltext

Verfügbarkeit prüfen

Immunocorrective effect of cycloferon and thymogen in patients with uterine cancer

Likars'ka sprava, 2000-10 (7-8), p.100

Antipova, S V

2000

Link zum Volltext

Verfügbarkeit prüfen

The use of gonadotrophin-releasing hormone antagonists in polycystic ovarian disease

Baillière's clinical obstetrics and gynaecology, 1998-12, Vol.12 (4), p.607-618

1998

Link zum Volltext

Verfügbarkeit prüfen

Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy

Federation proceedings, 1984-04, Vol.43 (5), p.1314

1984

Link zum Volltext

Verfügbarkeit prüfen

Acute antihypertensive synergism of angiotensin-converting enzyme inhibitors and diuretics

Federation proceedings, 1984-04, Vol.43 (5), p.1346

1984

Link zum Volltext

Verfügbarkeit prüfen

A randomized controlled trial of the efficacy and safety of saxagliptin as add-on therapy in patients with type 2 diabetes and inadequate glycaemic control on metformin plus a sulphonylurea

Diabetes, obesity & metabolism, 2014-05, Vol.16 (5), p.443-450

2014

Link zum Volltext

Verfügbarkeit prüfen

Saxagliptin/dapagliflozin is non‐inferior to insulin glargine in terms of β‐cell function in subjects with latent autoimmune diabetes in adults: A 12‐month, randomized, comparator‐controlled pilot study

Diabetes, obesity & metabolism, 2024-05, Vol.26 (5), p.1670-1677

2024

Link zum Volltext

Verfügbarkeit prüfen

Tolerability of saxagliptin in patients with inadequately controlled type 2 diabetes: results from 6 phase III studies

Journal of managed care pharmacy, 2014-02, Vol.20 (2), p.120-129

Davidson, Jaime A

2014

Link zum Volltext

Verfügbarkeit prüfen

The effect of thymogen on the state of immunity in destructive pulmonary tuberculosis

Voenno-medicinskij ̆zurnal, 1999-10, Vol.320 (10), p.65

1999

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy of pulmonary tuberculosis

Problemy tuberkuleza, 1998 (6), p.23

1998

Link zum Volltext

Verfügbarkeit prüfen

Effect of thymus preparations and anti-tuberculosis agents on immunologic reactivity and the course of the tuberculosis process in experimental animals

Problemy tuberkuleza, 1991 (12), p.52

1991

Link zum Volltext

Verfügbarkeit prüfen

Muramyl peptides and polyinosinic-polycytodylic acid given to mice prior to influenza virus challenge reduces pulmonary disease and mortality

Journal of biological response modifiers, 1990-02, Vol.9 (1), p.98-102

1990

Link zum Volltext

Verfügbarkeit prüfen

Recent studies on bleomycin

Lloydia, 1977-01, Vol.40 (1), p.67

Umezawa, H

1977

Link zum Volltext

Verfügbarkeit prüfen

Reproducibility of acute captopril-induced renal insufficiency with enalapril

Klinische Wochenschrift, 1984-01, Vol.62 (1), p.43

Cremer, W

1984

Link zum Volltext

Verfügbarkeit prüfen

1 – 21 von 21

Suche als RSS-Feed

Aktive Filter

KollektionSage Journals

Nur zeigenGeprüft (Peer-Review)

KollektionMEDLINE

ThemaDrug Therapy, Combination

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(11)

Publikationsform

Artikel
(21)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(17)
Life Sciences & Biomedicine
(13)
Science & Technology
(13)
Treatment Outcome
(13)
Dipeptides - Therapeutic Use
(12)
Female
(11)
Male
(10)
Adamantane - Analogs & Derivatives
(9)
Adult
(9)
Diabetes Mellitus, Type 2 - Drug Therapy
(9)
Diabetes
(8)
Middle Aged
(8)
Aged
(7)
Endocrinology & Metabolism
(7)
Hypoglycemic Agents - Therapeutic Use
(7)
Adamantane - Therapeutic Use
(6)
Diabetes Mellitus
(6)
Dipeptides - Administration & Dosage
(6)
Adjuvants, Immunologic - Therapeutic Use
(5)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sustained 52‐week efficacy and safety of triple therapy with dapagliflozin plus saxagliptin versus dual therapy with sitagliptin added to metformin in patients with uncontrolled type 2 diabetes

Efficacy and tolerability of saxagliptin compared with glimepiride in elderly patients with type 2 diabetes: a randomized, controlled study (GENERATION)

Efficacy and safety of saxagliptin compared with acarbose in Chinese patients with type 2 diabetes mellitus uncontrolled on metformin monotherapy: Results of a Phase IV open‐label randomized controlled study (the SMART study)

Initial combination therapy with saxagliptin and metformin provides sustained glycaemic control and is well tolerated for up to 76 weeks

Saxagliptin and sitagliptin in adult patients with type 2 diabetes: a systematic review and meta-analysis

Saxagliptin: A New Dipeptidyl Peptidase-4 Inhibitor for Type 2 Diabetes

Combination of antioxidants and a hepatoprotector in the treatment of patients with diabetic distal symmetric polyneuropathy

Effect of a complex treatment, including glutargin and erbisol on the blood plasma content of protein P53, apoptotic markers of type II, activity of caspases and the level of sCD 117 in patients with autonomic-vascular dystonia

Immunocorrective effect of cycloferon and thymogen in patients with uterine cancer

The use of gonadotrophin-releasing hormone antagonists in polycystic ovarian disease

Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy

Acute antihypertensive synergism of angiotensin-converting enzyme inhibitors and diuretics

A randomized controlled trial of the efficacy and safety of saxagliptin as add-on therapy in patients with type 2 diabetes and inadequate glycaemic control on metformin plus a sulphonylurea

Saxagliptin/dapagliflozin is non‐inferior to insulin glargine in terms of β‐cell function in subjects with latent autoimmune diabetes in adults: A 12‐month, randomized, comparator‐controlled pilot study

Tolerability of saxagliptin in patients with inadequately controlled type 2 diabetes: results from 6 phase III studies

The effect of thymogen on the state of immunity in destructive pulmonary tuberculosis

Immunotherapy of pulmonary tuberculosis

Effect of thymus preparations and anti-tuberculosis agents on immunologic reactivity and the course of the tuberculosis process in experimental animals

Muramyl peptides and polyinosinic-polycytodylic acid given to mice prior to influenza virus challenge reduces pulmonary disease and mortality

Recent studies on bleomycin

Reproducibility of acute captopril-induced renal insufficiency with enalapril

Aktive Filter

Suchergebnisse filtern